The Use of Inhaled Nitric Oxide in Newborn Medicine

Heart Disease

Volumn 2, Issue 5, 2000, Pages 342-347

  Golombek, Sergio G ^a  

^a WESTCHESTER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NITRIC OXIDE; VASODILATOR AGENT;

HUMAN; INHALATIONAL DRUG ADMINISTRATION; METABOLISM; NEWBORN; PULMONARY HYPERTENSION; REVIEW;

ADMINISTRATION, INHALATION; HUMAN; HYPERTENSION, PULMONARY; INFANT, NEWBORN; NITRIC OXIDE; VASODILATOR AGENTS;

EID: 0034281331     PISSN: 1521737X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (53)

1. Koshland DE. The molecule of the year. Science 1992;258:1861-1863.
2. Abman SH, Kinsella JP. Nitric oxide in the pathophysiology and treatment of neonatal pulmonary hypertension. Neonatal Respiratory Diseases 1994;4:1-6.
3. Furchgott RF, Zawadski JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 1980;288:373-376.
4. Griffith TM, Edwards DH, Lewis MJ, et al. The nature endothelium-derived vascular relaxing factor. Nature 1984;308:645-647.
5. Ignarro LJ, Buga GM, Wood KS, et al. Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc Natl Acad Sci USA 1987;84:9265-9269.
6. Palmer RMJ, Ferrige AG, Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 1987;327: 524-526.
7. Skimming JW. Nitric oxide inhalation therapy for newborn infants. Curr Probl Pediatr 1998;27:253-264.
8. Stamler JS, Singel DJ, Loscalzo J. Biochemistry of nitric oxide and its redox activated forms. Science 1992;258:1898-1902.
9. Nelin LD, Hoffman GM. The use of inhaled nitric oxide in a wide variety of clinical problems. Pediatr Clin North Am 1998;45:531-548.
10. Aranda M, Pearl RG. The biology of nitric oxide. Respir Care 1999;44:156 166.
11. Greene JH, Klinger JR. The efficacy of inhaled nitric oxide in the treatment of acute respiratory distress syndrome. An evidence-based medicine approach. Crit Care Clin 1998;14:387-409.
12. Schmidt HH, Lohmann SM, Walter U. The nitric oxide and cGMP signal transduction system: Regulation and mechanism of action. Biochemistry Biophys Acta 1993;1178:153-175.
13. Freeman B. Free radical chemistry of nitric oxide. Chest 1994;105:79S-84S.
14. Lefer AM. Nitric oxide: Nature's naturally occurring leukocyte inhibitor. Cir culation 1997;95:553-554.
15. Frostelli C, Frattacci MD, Wain JC, et al. Inhaled nitric oxide. A selective pulmonary vasodilator reversing hypoxic pulmonary vasoconstriction. Circulation 1991;83:2038-2047.
16. Roberts JD, Polaner DM, Lang P, et al. Inhaled NO in persistent pulmonary hypertension of the newborn. Lancet 1992;340:818-819.
17. Kinsella JP, Neish SR, Shaffer E, et al. Low-dose inhalational nitric oxide in persistent pulmonary hypertension of the newborn. Lancet 1992;340:819-820.
18. Kinsella JP, Neish SR, Ivy DD, et al. Clinical responses to prolonged treatment of persistent pulmonary hypertension of the newborn with low doses of inhaled nitric oxide. J Pediatr 1993;123:103-108.
19. Roberts JD, Lang P, Bigatello LM, et al. Inhaled NO in congenital heart disease. Circulation 1993;87:447-453.
20. Zapol WM, Hurfor W. Inhaled NO in adult respiratory distress syndrome and other lung disease. New Horiz 1993;1:638-650.
21. Abman SH, Kinsella JP, Schaffer MS, et al. Inhaled NO in the management of a preterm newborn with severe respiratory distress and pulmonary hypertension. Pediatrics 1993;92:606-609.
22. Finer NN, Etches PC, Kamstra B, et al. Inhaled nitric oxide in infants referred for extracorporeal membrane oxygenation. J Pediatr 1994;124:302-308.
23. Oriot D, Boussemart T, Berthier M, et al. Paradoxical effect of inhaled NO in a newborn with pulmonary hypertension [letter]. Lancet 1993;342:364-365.
24. Buhrer C, Merker G, Falke K, et al. Dose response to inhaled NO in acute hypoxemic failure of newborn infants: A preliminary report. Pediatr Pulmonol 1995;19:291-298.
25. Roberts JD Jr. Nitric oxide and the perinatal pulmonary circulation. In, Polin RA, Fox WW (eds). Fetal ant Neonatal Physiology, 2nd ed. Philadelphia, PA: W.B. Saunders Company, 1998:970-977.
26. Hurford WE. Conference summary: is inhaled nitric oxide therapeutic? Respir Care 1999;44:360-365.
27. Ehrenkranz RA, for the Neonatal Inhaled Nitric Oxide Study Group. Inhaled nitric oxide in full-term and nearly full-term infants with hypoxic respiratory failure. N Engl J Med 1997;336:597-604.
28. Kinsella JP, Truog WE, Walsh WF, et al. Randomized, multicenter trial of inhaled nitric oxide and high-frequency oscillatory ventilation in severe, persistent pulmonary hypertension of the newborn. J Pediatr 1997;131:55-62.
29. Roberts JD Jr, Fineman JR, Morin FC, et al. Inhaled nitric oxide and persistent pulmonary hypertension of the newborn. N Engl J Med 1997;336:605-610.
30. Mercier JC, Franco-Belgium Collaborative NO Trial Group. Early compared with delayed inhaled nitric oxide in moderately hypoxaemic neonates with respiratory failure: a randomised controlled trial. Lancet 1999;354:1066-1071.
31. Davidson D, Barefield ES, Kattwinkel J, et al. Inhaled nitric oxide for the early treatment of persistent pulmonary hypertension of the term newborn: a randomized, double-masked, placebo-controlled, dose-response, multicenter study. Pediatrics 1998;101:325-334.
32. Wessel DL, Adatia I, Van Marter LJ, et al. Improved oxygenation in a randomized trial of inhaled nitric oxide for persistent pulmonary hypertension of the newborn. Pediatrics 1997;100:E7.
33. Goldman AP, Tasker RC, Haworth SG, et al. Four patterns of response to inhaled nitric oxide for persistent pulmonary hypertension of the newborn. Pediatrics 1996;98:706-713.
34. Hoehn T, Krause M, Hentschel R. High-frequency ventilation augments the effect of inhaled nitric oxide in persistent pulmonary hypertension of the newborn. Eur Respir J 1998;11:234-238.
35. Day RW, Lynch JM, White KS, et al. Acute responses to inhaled nitric oxide in newborns with respiratory failure and pulmonary hypertension. Pediatrics 1996; 98:698-705.
36. Mercier JC, Lacaze T, Storme L, et al. Disease-related response to inhaled nitric oxide in newborns with severe hypoxaemic respiratory failure. Eur J Pediatr 1998;157:747-752.
37. Barefield ES, Karle VA, Phillips JR III, et al. Inhaled nitric oxide in term infants with hypoxemic respiratory failure. J Pediatr 1996;129:279-286.
38. Nakagawa TA, Morris A, Gomez RJ, et al. Dose response to inhaled nitric oxide in pediatric patients with pulmonary hypertension and acute respiratory distress syndrome. J Pediatr 1997;131:63-69.
39. Dobyns EL, Cornfield DN, Anas NG, et al. Multicenter randomized controlled trial of the effects of inhaled nitric oxide therapy on gas exchange in children with acute hypoxemic respiratory failure. J Pediatr 1999;134:406-412.
40. Skimming JW, Bender KA, Hutchinson AA, et al. Nitric oxide inhalation in infants with respiratory distress syndrome. J Pediatr 1997;130:225-230.
41. Kinsella JP, Walsh WF, Bose CL, et al. Inhaled nitric oxide in premature neonates with severe hypoxaemic respiratory failure: a randomised controlled trial. Lancet 1999;354:1061-1065.
42. Clark RH, Kueser TJ, Walker MW, et al. Low-dose nitric oxide therapy for persistent pulmonary hypertension of the newborn. N Engl J Med 2000;342: 469-474.
43. Ivy DD, Kinsella JP, Ziegler JW, et al. Dipyridamole attenuates rebound pulmonary hypertension after inhaled nitric oxide withdrawal in postoperative congenital heart disease. J Thorac Cardiovasc Surg 1998;115:875-882.
44. Davidson D, Barefield ES, Kattwinkel J, et al. Safety of withdrawing inhaled nitric oxide therapy in persistent pulmonary hypertension of the newborn. Pediatrics 1999;104:231-236.
45. Rosenberg AA, Kennaugh JM, Moreland, et al. Longitudinal follow-up of a cohort of newborn infants treated with inhaled nitric oxide for persistent pulmonary hypertension. J Pediatr 1997;131:70-75.
46. Cheung PY, Peliowski A, Robertson CM. The outcome of very low birth weight neonates (≤ 1500 g) rescued by inhaled nitric oxide: Neurodevelopment in early childhood. J Pediatr 1998;133:735-739.
47. Stork EK. The heart and blood vessels. In, Fanaroff AA, Maisels MJ, Stevenson DK (eds.) Year Book of Neonatal-Perinatal Medicine. St Louis, MO: Mosby, 1998:276-277.
48. Hallman M, Bry K, Turbow R, et al. Pulmonary toxicity associated with nitric oxide in term infants with severe respiratory failure. J Pediatr 1998;132:827-829.
49. George TN, Johnson KJ, Bates JN, et al. The effect of inhaled nitric oxide therapy on bleeding time and platelet aggregation in neonates. J Pediatr 1998; 132:731-734.
50. Roberts JD Jr. Inhaled nitric oxide for hypoxemic respiratory failure of the newborn. Respir Care 1999;44:169-173.
51. Kinsella JP, Abman SH. Controversies in the use of inhaled nitric oxide therapy in the newborn. Clin Perinatal 1998;25:203-217.
52. Kinsella JP, Abman SH, Nitric Oxide Study Group. High-frequency oscillatory ventilation augments the response to inhaled nitric oxide in persistent pulmonary hypertension of the newborn [abstract]. Chest 1998;114:1008S.
53. Finer NN, Barrington KJ. Nitric oxide in respiratory failure in full-term and nearly full-term newborn infants (Cochrane Review). In, The Cochrane Library, issue 3. Oxford, UK: Update Software; 1999.